{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:52:53Z","timestamp":1788065573217,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2017,9,22]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Understanding the relative risk of cardiovascular versus noncardiovascular death is important for designing clinical trials. These risks may differ depending on patient age, sex, and type of acute coronary syndrome (\n              <jats:styled-content style=\"fixed-case\">ACS<\/jats:styled-content>\n              ).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">IMPROVE<\/jats:styled-content>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">IT<\/jats:styled-content>\n              (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) was a randomized controlled trial of simvastatin plus either ezetimibe or placebo following stabilized\n              <jats:styled-content style=\"fixed-case\">ACS<\/jats:styled-content>\n              . Cause of death was adjudicated by an independent committee. We compared the cumulative incidence of cardiovascular and noncardiovascular death for patients with unstable angina\/non\u2010\n              <jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content>\n              \u2010segment elevation myocardial infarction (\n              <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">NSTEMI<\/jats:styled-content>\n              ) and\n              <jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content>\n              \u2010segment elevation myocardial infarction (\n              <jats:styled-content style=\"fixed-case\">STEMI<\/jats:styled-content>\n              ), in those &lt;65 and \u226565\u00a0years old, and males and females, over 7\u00a0years of follow\u2010up. Of 18\u00a0131 patients, the presenting event was\n              <jats:styled-content style=\"fixed-case\">STEMI<\/jats:styled-content>\n              for 5190 (29%) and\n              <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">NSTEMI<\/jats:styled-content>\n              for 12\u00a0941 (71%); 10\u00a0173 (56%) patients were &lt;65 years old and 7971 (44%) were \u226565\u00a0years old at presentation.\n              <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">NSTEMI<\/jats:styled-content>\n              patients were older than\n              <jats:styled-content style=\"fixed-case\">STEMI<\/jats:styled-content>\n              patients, with more cardiovascular and noncardiovascular risk factors. In\n              <jats:styled-content style=\"fixed-case\">STEMI<\/jats:styled-content>\n              patients, the cumulative incidence of cardiovascular death was higher for \u223c4\u00a0years following the index event, after which noncardiovascular death predominated. In\n              <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">NSTEMI<\/jats:styled-content>\n              patients, the cumulative incidence of cardiovascular death remained higher than noncardiovascular death over the full follow\u2010up period. Patients \u226565 years old and &lt;65\u00a0years old had a higher incidence of cardiovascular death than noncardiovascular death over the entirety of follow\u2010up. Female patients had a higher incidence of cardiovascular death than noncardiovascular death for \u223c6\u00a0years following the index event; male patients had a higher incidence of cardiovascular death than noncardiovascular death over the entirety of follow\u2010up.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Among post\u2010\n              <jats:styled-content style=\"fixed-case\">ACS<\/jats:styled-content>\n              patients enrolled in a long\u2010term clinical trial, the relative incidence of cardiovascular and noncardiovascular death differed based on type of\n              <jats:styled-content style=\"fixed-case\">ACS<\/jats:styled-content>\n              presentation and sex, but not age. These findings further delineate long\u2010term prognosis after\n              <jats:styled-content style=\"fixed-case\">ACS<\/jats:styled-content>\n              and should inform the design of future cardiovascular outcomes trials.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.117.005840","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:20:13Z","timestamp":1505780413000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long\u2010Term Follow\u2010Up After Acute Coronary Syndromes"],"prefix":"10.1161","volume":"6","author":[{"given":"Alexander C.","family":"Fanaroff","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"},{"name":"Division of Cardiology, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Roe","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"},{"name":"Division of Cardiology, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Clare","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Lokhnygina","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Navar","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"},{"name":"Division of Cardiology, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[{"name":"Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Wiviott","sequence":"additional","affiliation":[{"name":"Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Tershakovec","sequence":"additional","affiliation":[{"name":"Merck &amp; Co. Inc., Kenilworth, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Braunwald","sequence":"additional","affiliation":[{"name":"Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Blazing","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"},{"name":"Division of Cardiology, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02489-X"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.09.010"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm031"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.12.002"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.865352"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.06.003"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.07.008"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.799981"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.02.083"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.05.019"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi002"},{"key":"e_1_3_4_13_2","first-page":"24","article-title":"Clinical predictors of late death in survivors of acute myocardial infarction","volume":"36","author":"Agarwal SK","year":"2009","unstructured":"Agarwal SK, Singla I, Hreybe H, Saba S. Clinical predictors of late death in survivors of acute myocardial infarction. Tex Heart Inst J. 2009;36:24\u201330.","journal-title":"Tex Heart Inst J"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.115.002312"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.01.102"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.10.2541"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.5.444"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/pst.200"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.02767.x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.07.023"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.05.004"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.2307\/2532940"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.18.1860"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.03.024"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.002790"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202063260605"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)87733-3"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.2307\/2530374"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.115.001841"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.046"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.06.070"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.117.005840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:48:50Z","timestamp":1715597330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.117.005840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,22]]}},"alternative-id":["10.1161\/JAHA.117.005840"],"URL":"https:\/\/doi.org\/10.1161\/jaha.117.005840","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]},"assertion":[{"value":"2017-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e005840"}}